USD10
NERV acciones
Acerca de Minerva NeurosciencesMinerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
USD10
NERV acciones
Acerca de Minerva NeurosciencesMinerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
No hay suficientes datos
CAPITALIZACIÓN DE MERCADO
326,29 M US$
PRECIO DE APERTURA
8,00 US$
BAJO (1Y)
1,15 US$
ALTO (1Y)
12,46 US$
BAJO (24H)
7,52 US$
Alza (24H)
8,17 US$
Volumen (24 h)
2,26 M US$
253,92 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | 8,00 US$ | |
1 día | 7,54 US$ | 0,00 % |
1 semana | 7,74 US$ | |
1 mes | 6,27 US$ | |
1 año | 1,85 US$ |
Una nueva era de Coinbase ha comenzado
El futuro del dinero está aquí. Sé uno de los primeros en obtener acceso y probar nuevas funciones en cuanto estén disponibles.
Crea una cuenta ahora